Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
about
Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney diseaseIon Channels in the HeartHeart failure and Alzheimer's diseaseAtrial fibrillation: effects beyond the atrium?Atrial fibrillation in heart failure: an innocent bystander?NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Advances in the management of heart failure: the role of ivabradineThe Efficacy of Written Information Intervention in Reduction of Hospital Re-admission Cost in Patients With Heart Failure; A Systematic Review and Meta-AnalysisEpidemiology, diagnosis, and management of atrial fibrillation in womenAnticoagulation in Heart Failure: a ReviewEpidemiology of atrial fibrillation: European perspectiveManagement Of Atrial Fibrillation In Patients With Heart FailurePro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atriaHypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusionRecent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study).Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.A new algorithm to diagnose atrial ectopic origin from multi lead ECG systems--insights from 3D virtual human atria and torso.Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure.Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mappingA tale of two tachycardias.3D virtual human atria: A computational platform for studying clinical atrial fibrillationThe association of left atrial low-voltage regions on electroanatomic mapping with low attenuation regions on cardiac computed tomography perfusion imaging in patients with atrial fibrillation.Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity.Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.Atrial fibrillation and mortality in heart failure: a community study.Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Cadmium exposure and incidence of heart failure and atrial fibrillation: a population-based prospective cohort studyBurden of Comorbidities and Functional and Cognitive Impairments in Elderly Patients at the Initial Diagnosis of Heart Failure and Their Impact on Total Mortality: The Cardiovascular Health Study.Novel non-invasive algorithm to identify the origins of re-entry and ectopic foci in the atria from 64-lead ECGs: A computational study.Anticoagulation in Heart Failure: a Review.Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.Heterogeneous and anisotropic integrative model of pulmonary veins: computational study of arrhythmogenic substrate for atrial fibrillationAn update on the prognosis of patients with atrial fibrillation.Atrial fibrillation in heart failure: The sword of Damocles revisited.Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillationClinical Effect of Left Ventricular Dysfunction in Patients with Mitral Stenosis after Mitral Valve Replacement.Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.Rate Control in Atrial Fibrillation: Avoiding Morbidity.
P2860
Q26801625-7C4A9B1B-719C-4DA8-B013-7F93DF5B5DE2Q26829681-ABD00E9E-C763-454D-9901-86CBFEA3BBB6Q26852526-5FAA1DF4-B8FF-4722-A802-633EC40505AAQ26864877-767D39AC-3DFD-4F85-8619-AF08615F9C0FQ27010588-45BC22FC-8D13-47E5-AF69-1CBDACFE0FE1Q28072348-D60D55D3-B0D5-4D53-A3BF-AC48ACD06941Q28072418-705A4895-2149-4991-8F64-FC55F2171B9BQ28081907-5A4C36A7-679B-49BF-B5B0-F43762AB8F3FQ28083655-30EF0317-46A2-4AD4-A9E3-A7BA70A2A000Q28087068-0379B9FD-302D-440A-9128-296A679A441BQ28315439-199F1DC3-677A-40BB-81F6-D87341089E3BQ30354835-7EE1FDBA-C190-42B9-84EF-49F51F86202EQ30545769-FB508D7A-F85F-4D91-9D65-A632873FEE32Q33410368-066A714B-8D88-4DEF-94A2-E2611970B40EQ34023229-44515708-55E2-4EF9-9B29-52F0A661C3BBQ34413880-4036D811-906D-4AF7-B51E-1150F60E6B31Q34651371-FF16A5C9-33CB-4E91-896C-03D997FC9CF1Q34836591-6FBDA52A-A4B5-411F-9966-852BD2CF1CB6Q35001458-E6DB8E5A-A4C4-40E8-8706-0E89F14D70EEQ35020050-AF39DD28-C8B3-4E75-A44E-3B72D885F194Q35068578-8857536D-2CD3-4536-A6F1-8088A38F2D1FQ35076306-6176F11F-EF9B-4B5D-B4F8-016F05A38613Q35536198-A7C58170-851B-49C4-BE9D-E1BE6E646599Q35539130-ADB0FA41-AB4B-4BFA-9704-654C922D92DAQ35554746-B9BC1214-891F-46B8-B4F6-32050027E341Q35563922-EF7E496E-B42C-4B4B-A25A-DB79418FD6D5Q35569621-C1E35198-FA26-4812-B0C0-DAA566499C67Q35752584-4768BD8C-1DFA-4817-A8E4-B295A2069838Q35778934-A462E595-732A-4A71-9CB4-93994F04C9B8Q35842447-B4A4F862-F80C-4C8A-8116-6C75B376DA36Q36295154-D38C2093-29B0-4C14-A98A-EC8776C04212Q36381170-3145E307-14D8-490B-BAED-99156533FC0FQ36528021-F9944E0E-DEFE-4863-B60D-D4DC108DA620Q36801442-C284F139-C973-45F5-8A29-F77A0A75BB6AQ36919478-FEC44BA4-472E-4C8A-8AD6-6147B02E9EB6Q37043226-0DFE216A-BE81-4843-B268-C84D8481E9EBQ37106753-4EBC619C-5E18-439D-B9F5-42F048498048Q37329028-4FE8942F-1BB2-461E-978F-E1F564F3CAFEQ37418226-ECC3CD32-1C2D-4904-9DBA-2097D71849EDQ37496104-8BD95132-40E5-4EA4-90AA-66900C7FDFF2
P2860
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
@en
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
@nl
type
label
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
@en
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
@nl
prefLabel
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
@en
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.
@nl
P1433
P1476
Atrial fibrillation and heart failure: treatment considerations for a dual epidemic
@en
P2093
David J Callans
Elad Anter
P304
P356
10.1161/CIRCULATIONAHA.108.821306
P407
P577
2009-05-01T00:00:00Z